Quidelortho share price today
(NASDAQ: QDEL)

Name: Quidelortho Share Price Today (NASDAQ: QDEL) - Quidelortho Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Quidelortho share price is $44.33 & ₹3,834.10 as on 24 Jan 2025, 2.30 'hrs' IST

$44.33

▲

-0.15

(-0.34%)

Market is closed - opens 8 PM, 24 Jan 2025

View live Quidelortho share price in Dollar and Rupees. Guide to invest in Quidelortho stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Quidelortho, along with analyst recommendations, forecasts, and comprehensive financials.

Quidelortho share price movements

Today's Low: $43.01
Today's High: $44.95
$44.33
2.98%
Downside
Day's Volatility :4.32%
Upside
1.38%
52 Weeks Low: $29.74
52 Weeks High: $73.19
$44.33
32.92%
Downside
52 Weeks Volatility :59.37%
Upside
39.43%

Quidelortho Returns

Period	Quidelortho Corp	Sector (Health Care)	Index (Russel 2000)
3 Months	14.99%	-5.5%	0.0%
6 Months	14.32%	-4.3%	0.0%
1 Year	-36.45%	1.6%	0.0%
3 Years	-55.12%	9.8%	-11.0%

Quidelortho Key Statistics

in dollars & INR

Previous Close	$44.48
Open	$44.6
Today's High	$44.95
Today's Low	$43.01
Market Capitalization	$2.9B
Today's Volume	$907.9K
52 Week High	$73.19
52 Week Low	$29.735
Revenue TTM	$2.8B
EBITDA	$586.5M
Earnings Per Share (EPS)	$-27.81
Profit Margin	-66.25%
Quarterly Earnings Growth YOY	-0.77%
Return On Equity TTM	-45.79%

How to invest in Quidelortho Stock (QDEL) from India?

It is very easy for Indian residents to invest directly in Quidelortho from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Quidelortho stock in both Indian Rupees (INR) and US Dollars (USD). Search for Quidelortho or QDEL on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Quidelortho or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Quidelortho shares which would translate to 0.020 fractional shares of Quidelortho as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Quidelortho, in just a few clicks!

Returns in Quidelortho for Indian investors in Rupees

Investment Value

₹1,00,000

Quidelortho investment value today

Current value as on today

₹67,392

Returns

₹32,608

(-32.61%)

Returns from Quidelortho Stock

₹36,662 (-36.66%)

Dollar Returns

₹4,054 (+4.05%)

Indian investors sentiment towards Quidelortho

-13%

Period: Oct 25, 2024 to Jan 23, 2025. Change in 30 Days versus previous period

Search volume for Quidelortho on INDmoney from India has reduced in the last 30 days as on Jan 24, 2025. -13% less investors are searching Quidelortho in the last 30 days versus the previous period.

Global Institutional Holdings in Quidelortho

T. Rowe Price Investment Management,Inc.
13.97%
The Carlyle Group Inc
12.28%
BlackRock Inc
10.81%
Vanguard Group Inc
9.00%
Rubric Capital Management LP
6.24%
Amvescap Plc.
2.99%

Analyst Recommendation on Quidelortho

Buy

61%Buy

30%Hold

7%Sell

Based on 13 Wall street analysts offering stock ratings for Quidelortho(by analysts ranked 0 to 5 stars)

Based on 13 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Quidelortho

What analysts predicted

Upside of 15.37%

Target:

$51.14

Current:

$44.33

Insights on Quidelortho

Price Movement
In the last 7 days, QDEL stock has moved up by 6.2%
Increasing Revenue
Revenue is up for the last 2 quarters, 636.3M → 727.1M (in $), with an average increase of 12.5% per quarter
Increasing Net Profit
Netprofit is up for the last 3 quarters, -1.70B → -19.9M (in $), with an average increase of 848.6% per quarter
QDEL vs BSX (1 yr)
In the last 1 year, Boston Scientific Corp. has given 65.5% return, outperforming this stock by 103.9%
QDEL vs BSX (3 yr)
In the last 3 years, Boston Scientific Corp. has given 133.4% return, outperforming this stock by 191.0%
Price to Sales
ForQDEL every $1 of sales, investors are willing to pay $1.1, whereas for Boston Scientific Corp., the investors are paying $9.3 for every $1 of sales.

Quidelortho Financials in INR & Dollars

	FY19	Y/Y Change
Revenue	$534.9M	↑ 2.41%
Net Income	$72.9M	↓ 1.7%
Net Profit Margin	13.63%	↓ 0.57%

	FY20	Y/Y Change
Revenue	$1.7B	↑ 210.66%
Net Income	$810.3M	↑ 1011.18%
Net Profit Margin	48.76%	↑ 35.13%

	FY21	Y/Y Change
Revenue	$1.7B	↑ 2.22%
Net Income	$704.2M	↓ 13.09%
Net Profit Margin	41.46%	↓ 7.3%

	FY22	Y/Y Change
Revenue	$3.3B	↑ 92.28%
Net Income	$548.7M	↓ 22.08%
Net Profit Margin	16.8%	↓ 24.66%

	FY23	Y/Y Change
Revenue	$3.0B	↓ 8.34%
Net Income	$-10.1M	↓ 101.84%
Net Profit Margin	-0.34%	↓ 17.14%

	FY24	Y/Y Change
Revenue	$3.0B	↑ 0.14%
Net Income	$-10.1M	↑ 0.0%
Net Profit Margin	-0.34%	↑ 0.0%

	Q2 FY23	Q/Q Change
Revenue	$665.1M	↓ 21.39%
Net Income	$-53.2M	↓ 209.02%
Net Profit Margin	-8.0%	↓ 13.77%

	Q3 FY23	Q/Q Change
Revenue	$744.0M	↑ 11.86%
Net Income	$-12.7M	↓ 76.13%
Net Profit Margin	-1.71%	↑ 6.29%

	Q4 FY23	Q/Q Change
Revenue	$742.6M	↓ 0.19%
Net Income	$7.0M	↓ 155.12%
Net Profit Margin	0.94%	↑ 2.65%

	Q1 FY24	Q/Q Change
Revenue	$709.7M	↓ 4.43%
Net Income	$-1.7B	↓ 24471.43%
Net Profit Margin	-240.38%	↓ 241.32%

	Q2 FY24	Q/Q Change
Revenue	$636.3M	↓ 10.34%
Net Income	$-147.7M	↓ 91.34%
Net Profit Margin	-23.21%	↑ 217.17%

	Q3 FY24	Q/Q Change
Revenue	$727.1M	↑ 14.27%
Net Income	$-19.9M	↓ 86.53%
Net Profit Margin	-2.74%	↑ 20.47%

	FY19	Y/Y Change
Profit	$320.8M	↑ 1.61%

	FY20	Y/Y Change
Profit	$1.3B	↑ 320.46%

	FY21	Y/Y Change
Profit	$1.3B	↓ 5.78%

	FY22	Y/Y Change
Profit	$1.9B	↑ 52.33%

	FY23	Y/Y Change
Profit	$1.3B	↓ 33.71%

	FY24	Y/Y Change
Profit	$1.5B	↑ 16.44%

	Q2 FY23	Q/Q Change
Profit	$296.4M	↓ 33.93%

	Q3 FY23	Q/Q Change
Profit	$368.1M	↑ 24.19%

	Q4 FY23	Q/Q Change
Profit	$320.0M	↓ 13.07%

	Q1 FY24	Q/Q Change
Profit	$277.8M	↓ 13.19%

	Q2 FY24	Q/Q Change
Profit	$223.5M	↓ 19.55%

	Q3 FY24	Q/Q Change
Profit	$352.3M	↑ 57.63%

	FY19	Y/Y Change
Operating Cash Flow	$134.5M	↓ 1.36%
Investing Cash Flow	$-27.2M	↓ 123.69%
Financing Cash Flow	$-98.3M	↓ 59.73%

	FY20	Y/Y Change
Operating Cash Flow	$629.8M	↑ 368.28%
Investing Cash Flow	$-63.3M	↑ 132.55%
Financing Cash Flow	$-130.3M	↑ 32.55%

	FY21	Y/Y Change
Operating Cash Flow	$805.9M	↑ 27.96%
Investing Cash Flow	$-319.5M	↑ 404.61%
Financing Cash Flow	$-173.2M	↑ 32.93%

	FY22	Y/Y Change
Operating Cash Flow	$885.3M	↑ 9.86%
Investing Cash Flow	$-1.6B	↑ 414.57%
Financing Cash Flow	$252.0M	↓ 245.52%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-30.6M	↓ 116.2%
Investing Cash Flow	$-42.3M	↓ 38.61%
Financing Cash Flow	$-99.7M	↑ 67.28%

	Q3 FY23	Q/Q Change
Operating Cash Flow	$41.5M	↓ 235.62%
Investing Cash Flow	$-21.3M	↓ 49.65%
Financing Cash Flow	$-48.7M	↓ 51.15%

Quidelortho Technicals Summary

Sell

Neutral

Buy

Quidelortho is currently in a favorable trading position ( BUY ) according to technical analysis indicators.

Quidelortho Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Quidelortho Corp	-0.27%	14.32%	-36.45%	-55.12%	-43.69%
Medtronic Plc	7.73%	11.61%	2.39%	-15.68%	-26.33%
Edwards Lifesciences Corp.	-8.41%	10.69%	-6.13%	-36.94%	-9.52%
Boston Scientific Corp.	10.15%	33.89%	64.9%	135.97%	135.19%
Stryker Corporation	5.32%	17.73%	25.19%	56.65%	81.96%
Abbott Laboratories	2.63%	11.92%	4.74%	-4.45%	31.47%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Quidelortho Corp	9.72	NA	7.19	1.8	-0.46	0.01	NA	47.42
Medtronic Plc	27.03	27.03	1.5	5.46	0.08	0.04	0.03	38.29
Edwards Lifesciences Corp.	26.66	26.66	6.43	2.55	0.19	0.11	NA	16.18
Boston Scientific Corp.	83.4	83.4	1.79	2.46	0.09	0.05	NA	14.05
Stryker Corporation	42.47	42.47	2.68	12.06	0.19	0.07	0.01	52.86
Abbott Laboratories	34.45	34.45	2.2	4.67	0.15	0.06	0.02	22.94

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Quidelortho Corp	Buy	$2.9B	-43.69%	9.72	-66.25%
Medtronic Plc	Buy	$113.3B	-26.33%	27.03	12.06%
Edwards Lifesciences Corp.	Buy	$40.7B	-9.52%	26.66	65.86%
Boston Scientific Corp.	Buy	$148.7B	135.19%	83.4	11.26%
Stryker Corporation	Buy	$150.9B	81.96%	42.47	16.34%
Abbott Laboratories	Buy	$202.6B	31.47%	34.45	13.99%

About Quidelortho

QuidelOrtho Corporation provides diagnostic testing solutions. The company operates through Labs, Transfusion Medicine, Point-of-Care, and Molecular Diagnostics business units. The Labs business unit provides clinical chemistry laboratory instruments and tests that measure target chemicals in bodily fluids for the evaluation of health and the clinical management of patients; immunoassay laboratory instruments and tests, which measure proteins as they act as antigens in the spread of disease, antibodies in the immune response spurred by disease, or markers of proper organ function and health; testing products to detect and monitor disease progression across a spectrum of therapeutic areas; and specialized diagnostic solutions. The Transfusion Medicine business unit offers immunohematology instruments and tests used for blood typing to ensure patient-donor compatibility in blood transfusions; and donor screening instruments and tests used for blood and plasma screening for infectious diseases. The Point-of-Care business unit provides instruments and tests to provide rapid results across a continuum of point-of-care settings. The Molecular Diagnostics business unit offers polymerase chain reaction thermocyclers; amplification systems; and sample-to-result molecular instruments and tests for syndromic infectious disease diagnostics. The company sells its products directly to end users through a direct sales force; and through a network of distributors for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, urgent care clinics, universities, retail clinics, pharmacies, wellness screening centers, blood banks, and donor centers, as well as for individual, non-professional, and over-the-counter use. It operates in North America, Europe, the Middle East, Africa, China, and internationally. The company was incorporated in 1979 and is headquartered in San Diego, California.

Organization	Quidelortho
Employees	7100
CEO	Mr. Joseph M. Busky CPA
Industry	Health Technology

Management People of Quidelortho

Name	Title
Mr. Joseph M. Busky CPA	Chief Financial Officer
Dr. Werner Kroll Ph.D.	Executive Officer
Mr. Brian J. Blaser	President, CEO & Director
Mr. Philip McLellan	Chief Operations Officer
Mr. Jonathan Siegrist Ph.D.	Executive VP of Research & Development and CTO
Ms. Juliet C. Cunningham	Vice President of Investor Relations
Ms. Michelle A. Hodges J.D.	Chief Legal Officer
Ms. Lisa S. Hayes	Vice President of Global Marketing & Corporate Communications
Mr. Ronald Lee Bowman	Chief Human Resources Officer
Mr. William J. Ferenczy	Point of Care Business Unit Leader

Important FAQs about investing in Quidelortho (QDEL) from India :

What is Quidelortho share price today?

Quidelortho share price today stands at $44.33, Open: $44.60 ; Previous Close: $44.48 ; High: $44.95 ; Low: $43.01 ; 52 Week High: $73.19 ; 52 Week Low: $29.74. The stock opens at $44.60, after a previous close of $44.48. The stock reached a daily high of $44.95 and a low of $43.01, with a 52-week high of $73.19 and a 52-week low of $29.74.

Can Indians buy Quidelortho shares?

Yes, Indians can invest in the Quidelortho (QDEL) from India.

With INDmoney, you can buy Quidelortho at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Quidelortho at zero transaction cost.

How can I buy Quidelortho shares from India?

It is very easy to buy Quidelortho from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Quidelortho be purchased?

Yes, you can buy fractional shares of Quidelortho with INDmoney app.

What are the documents required to start investing in Quidelortho stocks?

To start investing in Quidelortho, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.